Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework

Health Policy

Volumn 80, Issue 1, 2007, Pages 135-143

  Williams, Iestyn ^a   Bryan, Stirling ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Health economics; Policy decision making; Priority setting; Research utilisation

Indexed keywords

ARTICLE; COMPREHENSION; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; HEALTH CARE; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; RESEARCH UTILIZATION GROUP; RESOURCE ALLOCATION;

GREAT BRITAIN; HEALTH CARE RATIONING; MODELS, ECONOMETRIC; POLICY MAKING;

EID: 33751017108     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.03.006     Document Type: Article

References (45)

1. Drummond M.F., O'Brien B.J., Stoddart G.L., and Torrance G.W. Methods for the economic evaluation of health care programs (2005), Oxford Medical Publications
2. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine; 1997.
3. Walley T., Barton S., Cooke J., and Drummond M. Economic evaluations of drug therapy: attitudes of primary care prescribing advisors in Great Britain. Health Policy 41 (1997) 61-62
4. Drummond M., Cooke J., and Walley T. Economic evaluation under managed competition: evidence from the UK. Social Science and Medicine 45 4 (1997) 583-595
5. Hoffman C., and von der Schulenburg J.M.G. The use of economic evaluation studies in health care decision making - summary report. In: von der Schulenburg J.M.G. (Ed). The influence of economic evaluation studies on health care decision-making (2000), A European Survey IOS Press, Washington, DC
6. Elsinga E., and Rutten F.H. Economic evaluation in support of national health policy. The case of the Netherlands. Social Science and Medicine 45 4 (1997) 605-620
7. Lyles A., Luce B.R., and Rentz A.M. Managed care pharmacy, socioeconomic assessments and drug adoption decisions. Social Science and Medicine 45 4 (1997) 511-521
8. Luce R.B., and Brown R.E. The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States. International Journal of Technology Assessment in Health Care 11 1 (1995) 79-92
9. Sloan F.A., Whetten-Goldstein K., and Wilson A. Hospital pharmacy decisions, cost containment and the use of cost effectiveness analysis. Social Science and Medicine 45 4 (1997) 523-533
10. Motheral B.R., Grizzle A.J., Armstrong E.P., Cox E.R., and Fairman K. Role of pharmacoeconomics in drug benefit decision making: results of a survey. Formulary 35 (2000) 412-421
11. Black N. Evidence based policy: proceed with care. British Medical Journal 323 (2001) 4
12. Klein R. From evidence based medicine to evidence based policy?. Journal of Health Services Research and Policy 5 2 (2000) 65-66
13. Weiss C.H. The many meanings of research utilization. Public Administration Review (1979) 426-431
14. Lindblom C.E. The Science of muddling through. In: Theodoulou S., and Cahn M. (Eds). Public policy: the essential readings (1995), Prentice Hall 113-127
15. Tenbensel T. Health prioritisation as rationalist policy making: problems, prognoses and prospects. Policy and Politics 28 3 (2000) 425-440
16. Culyer A.J. The economics of social policy (1973), Martin Robertson, London
17. Williams A. Intergenerational equity: an exploration of the fair innings argument. Health Economics 6 2 (1997) 117-132
18. Klein R., and Williams A. Setting priorities: what is holding us back - inadequate information or inadequate institutions?. In: Coulter A., and Ham C. (Eds). The global challenge of health care rationing (2000), Open University Press, Buckingham 15-27
19. Elliott H., and Popay J. How are policy makers using evidence? Models of research utilisation and local NHS policy making. Journal of Epidemiology and Community Health 54 (2000) 461-469
20. Al M.J., Feenstra T., and Brouwer W.B.F. Decision makers' views on health care objectives and budget constraints: results from a pilot study. Health Policy 70 (2004) 33-48
21. Drummond M., and Weatherly H. Implementing the findings of health technology assessments. If the cat got out of the bag, can the tail wag the dog?. International Journal of Technology Assessment in Health Care 16 1 (2000) 1-12
22. Ross J. The use of economic evaluation in health care: Australian decision makers' perceptions. Health Policy 31 (1995) 103-110
23. Coast J. Citizens, their agents and health care rationing: an exploratory study using qualitative methods. Health Economics 10 (2001) 159-174
24. Syrett K. A Technocratic fix to the 'legitimacy problem'? The Blair government and health care rationing in the United Kingdom. Journal of Health Politics, Policy and Law 28 4 (2003) 715-746
25. Devlin N., and Parkin D. Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 13 (2004) 437-452
26. Milewa T., and Barry C. Health policy and the politics of evidence. Social Policy & Administration 39 5 (2005) 498-512
27. Freemantle N., and Mason J. Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate. British Medical Journal 318 (1999) 1480-1482
28. Estabrooks C. Research utilisation and qualitative research. In: Morse J.M., Swanson J.M., and Kuzel A.J. (Eds). The nature of qualitative evidence (2001), Sage Publications, London
29. Vuorenkoski L., Toiviainen H., and Hemminki E. Drug reimbursement in Finland - a case of explicit prioritising in special categories. Health Policy 66 (2003) 169-177
30. Newdick C. Evaluating new health technology in the English national health service. In: Jost T.S. (Ed). Health care coverage determinations. An international comparative study (2005), Open University Press, New York
31. Jenkings N.K., and Barber N. What constitutes evidence in hospital new drug decision making?. Social Science and Medicine 58 (2004) 1757-1766
32. Coast J. Is economic evaluation in touch with society's health values?. British Medical Journal 329 (2004) 1233-1236
33. Dowie J. The research-practice gap and the role of decision analysis in closing it. Health Care Analysis 4 (1996) 5-18
34. Mauskopf J.A., Paul J.E., Grant D.M., and Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 13 3 (1998) 277-288
35. Kernick D.P. The impact of health economics on healthcare delivery: a primary care perspective. Pharmacoeconomics 18 4 (2000) 311-315
36. Hutton J., and Brown R. Use of economic evaluation in decision making: what needs to change?. Value in Health 5 2 (2002) 65-66
37. Nixon J., Phipps K., Glanville J., Mugford M., and Drummond M. Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health. Applied Health Economics and Health Policy 1 4 (2002) 179-190
38. Haslé-Pham E., Arnould B., Späth H., Follet A., Duru G., and Marquis P. Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey. Health Policy 71 (2005) 205-212
39. Duthie T., Trueman P., Chancellor J., and Diez L. Research into the use of health economics in decision making in the United Kingdom - phase II is health economics 'for good or evil'?. Health Policy 46 (1999) 143-157
40. McDonald R. Using health economics in health services: rationing irrationally? (2002), Open University Press
41. Peacock S., and Richardson J. PBMA in South Australia: setting priorities in community health. HESG (1998)
42. Innvaer S., Vist G., Trommald M., and Oxman A.D. Health policy-makers' perceptions of their use of evidence: a systematic review. Journal of Health Services Research and Policy 7 4 (2002) 239-245
43. Lavis J.N., Robertson D., Woodside J.M., McLeod B., and Abelson J. How can research organisations more effectively transfer research knowledge to decision makers?. The Milbank Quarterly 81 2 (2003) 221-248
44. Lomas J. Finding audiences, changing beliefs: the structure of research use in Canadian health policy. Journal of Health Politics, Policy and Law 15 (1990) 525-542
45. Neumann P.J. Using cost-effectiveness analysis to improve health care. Opportunities and Barriers (2005), Oxford University Press, Oxford